Fogarty collaborates with components of the
National Institutes of Health and other partners to foster global health research on a variety of research and training opportunities involving low- and middle-income countries (LMICs).
Current Collaboration Funding Opportunities
Fogarty is participating in the following NIH-issued funding opportunity announcements and Notices of Special Interest (NOSIs).
Updated April 19, 2021
- Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations to Improve the AI/ML-Readiness of NIH-Supported Data (NOT-OD-21-094)
Expiration Date: May 27, 2021
- Dissemination and Implementation Research in Health
(R01 Clinical Trial Optional) (PAR-19-274),
(R03 Clinical Trial Not Allowed) (PAR-19-276) and
(R21 Clinical Trial Optional) (PAR-19-275)
Note: Fogarty is participating in the R03 and R21 mechanisms.
Expiration Date: May 8, 2022
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) (PA-20-275)
Expiration Date: July 24, 2023
Centers for AIDS Research (P30 Clinical Trial Not Allowed) (PAR-20-106)
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) (PAR-20-107)
Expiration Date: July 29, 2022
Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars (NOT-OD-20-054)
Expiration Date: March 6, 2023
Administrative Supplements for Research on Dietary Supplements (Admin Supp Clinical Trial Not Allowed) (PA-20-227)
Expiration Date: April 16, 2023
- Notices of Special Interest from the National Institute of Mental Health (NIMH):
Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets (NOT-MH-20-024)
Mental Health Comorbidities in HIV Prevention and Treatment (NOT-MH-20-013)
Strengthening the HIV Prevention Continuum (NOT-MH-20-019)
Strengthening the HIV Care Continuum (NOT-MH-20-023)
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (NOT-MH-20-035)
Submit applications using one of the listed funding opportunity announcements, including multiple Fogarty program announcements.
Applies to due dates through May 8, 2023.
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) (PA-21-071)
Expiration Date: May 8, 2023
- Ethical, Legal, and Social Implications (ELSI) Research
Expiration Date: July 20, 2023
- Fogarty is interested in supporting research on ethical issues related to human genome research relevant to low and middle income countries, in particular, studies conducted by investigators in these countries, through the
Small Research Grant Program (R03) (PA-20-257)
- Foreign institutions can also apply to the companion Research Project Grant
(R01) (PA-20-254) and Exploratory/Developmental Research Grant Award
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements
(Parent Admin Supp Clinical Trial Optional) (PA-20-272)
Expiration date: July 24, 2023
Ongoing Fogarty and NIH Global Health Collaborations
Fogarty is participating in the following collaborations with NIH components, U.S. government partners, and others.
African Postdoctoral Training Initiative (APTI)
The African Academy of Sciences (AAS), NIH and the Bill and Melinda Gates Foundation are partnering under the auspices of the Coalition of African Research and Innovation (CARI) to establish a post-doctoral training fellowship program, the
African Postdoctoral Training Initiative (APTI).
Basic Behavioral and Social Sciences Opportunity Network (OppNet)
NIH Basic Behavioral and Social Sciences Opportunity Network (OppNet) is a trans-NIH initiative to expand the agency's funding of basic behavioral and social sciences research. OppNet issues a variety of
funding opportunities to solicit research applications examining basic mechanisms of behavioral maintenance.
Chronic, noncommunicable diseases (NCDs) and HIV/AIDS
The NIH is leading the project
Research to Guide Practice: Enhancing HIV/AIDS platforms to address NCDs in low-resource settings in collaboration with the President's Emergency Plan for AIDS Relief (PEPFAR) and other partners. The project aims to bring together researchers, implementers and government representatives to articulate practical goals, approaches and a related research agenda to incorporate prevention, care and treatment for noncommunicable diseases into HIV/AIDS platforms in LMICs.
In June of 2010, NIH issued a
Notice to Highlight Current NIH Funding Opportunities that Promote Research on the Human Health Effects of Climate Change. Recognizing the need to address climate change, the Trans-NIH Working Group on Climate Change and Health held a workshop to identify research priorities and gaps, to devise methods for enhanced collaboration within the NIH and with other federal agencies in this area, and to review the NIH portfolio of projects directly or indirectly related to climate change.
Creative and Novel Ideas in HIV Research (CNIHR)
Creative and Novel Ideas in HIV Research (CNIHR), presented by the International AIDS Society in collaboration with the NIH and the NIH-funded Centers for AIDS Research (CFAR), aims to attract international and U.S.-based early stage investigators from outside the field of HIV research to help address key scientific questions in HIV research, including emerging issues of long-term survival with HIV infection, prevention of HIV transmission and research towards a cure.
Data Science: Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa)
The NIH Common Fund’s
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) program will explore how advances in data science applied in the African context can spur new health discoveries and catalyze innovation. This program will leverage existing data and technologies to develop solutions to the continent’s most pressing clinical and public health problems through a robust ecosystem of new partners from academic, government and private sectors. A working group of NIH components is guiding the program, led by Fogarty, the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the National Institute of Mental Health (NIMH), and the National Library of Medicine (NLM).
Global Alliance of Chronic Diseases
NIH participates in the
Global Alliance for Chronic Diseases (GACD), a collection of publicly funded research agencies that supports innovative research collaborations to address the prevention and treatment of chronic diseases in vulnerable populations.
Human Heredity and Health in Africa (H3Africa)
Human Heredity and Health in Africa (H3Africa) Initiative is a partnership between NIH, the African Society of Human Genetics and Wellcome Trust to foster genomic and epidemiological research in African scientific institutions.
- The trans-NIH
Dissemination and Implementation Research in Health program supports research to identify, develop, evaluate and refine effective and efficient methods, systems, infrastructures and strategies. Focusing on patient outcomes, supported programs will disseminate and implement research-tested health behavior change interventions, evidence-based prevention, early detection, diagnostic, treatment and management, quality of life improvement services, and data monitoring and surveillance reporting tools into public health and clinical practice settings.
- Apply through Dissemination and Implementation Research in Health R01 (PAR-19-274), R21 (PAR-19-275) and R03 (PAR-19-276). Fogarty is participating in the R21 and R03. Expires May 8, 2022.
NIH and PEPFAR Collaboration for Implementation Science administrative supplements: NIH and PEPFAR collaborated to provide administrative supplements for implementation science projects to directly inform PEPFAR programs in order to increase their impact, efficiency and sustainability. Current grantees were encouraged to develop partnerships with local researchers and researchers from other disciplines.
- NIH and PEPFAR collaborated to fund projects focused on Advancing Implementation Science in Prevention of Maternal-Child HIV Transmission (PMTCT).
Minority Health and Health Disparities Research Training (MHRT)
Minority Health and Health Disparities Research Training (MHRT) from the National Institute on Minority Health and Health Disparities (NIMHD) supports research training activities in minority health and health disparities research for individuals from diverse backgrounds, including groups underrepresented in biomedical, behavioral, clinical and social sciences research, at domestic institutions and at specified LMIC locations. This program is intended to promote both domestic and international training opportunities in a diverse and inclusive environment for eligible undergraduate, post-baccalaureate and graduate students, as well as for eligible residents, fellows and postdoctoral students.
Partnerships for Enhanced Engagement in Research (PEER)
Partnerships for Enhanced Engagement in Research (PEER) is a competitive grants program that invites scientists in developing countries, partnered with U.S. Government-supported collaborators, to apply for funds to support research and capacity-building activities on topics with strong potential development impacts. The program is supported by the U.S. Agency for International Development (USAID) with several U.S. Government-supported agencies, including NIH, and is implemented by the U.S. National Academies of Sciences, Engineering and Medicine (NASEM).
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network is a cooperative agreement research program to facilitate clinical research in rare diseases. Learn more about rare diseases at NIH from the
Office of Rare Diseases Research at the National Center for Advancing Translational Sciences (NCATS).
South Africa Collaborative Biomedical Research
The U.S.-South Africa Program for Collaborative Biomedical Research is a collaboration between NIH and the South Africa Medical Research Council (MRC). Most recently funding was available through
U01 requests for applications to support TB, HIV/AIDS biomedical and behavioral science, and HIV-related co-morbidities, including malignancies. Fogarty participated in the R01 and R21.
Sub-Saharan African Collaborative HIV and Cancer Consortia
Sub-Saharan African Collaborative HIV and Cancer Consortia, supported by Fogarty and the National Cancer Institute (NCI), will promote and facilitate research on HIV and cancer in Africa through collaborative efforts between investigators in the U.S. and investigators in sub-Saharan African countries.
Updated April 19, 2021